Literature DB >> 30216644

Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia.

Benjamin Ole Wolthers1, Pernille R Mogensen1,2, Thomas L Frandsen1, Jonas Abrahamsson3, Mikael Behrendtz4, Mats Heyman5, Olli Lohi6, Ulrika Norén-Nyström7, Ellen Ruud8, Kjeld Schmiegelow1,9.   

Abstract

Pancreatitis is a frequent toxicity to acute lymphoblastic leukemia (ALL) treatment, significantly associated with asparaginase use, and may be followed by severe complications such as acute hyperglycaemia, need for mechanical ventilation, pseudocysts, and death. Here, we provide novel data on seven patients diagnosed with diabetes after pancreatitis and still requiring insulin treatment after a median follow-up of 4.2 years (range: 1.7-9.2). We describe the clinical course of pancreatitis and illustrate the association between pancreatic pseudocysts, older age, and development of insulin-dependent diabetes. Together, this study documents the persisting burden of pancreatitis in childhood ALL and underlines the need for plasma glucose level monitoring.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute lymphoblastic leukemia; diabetes; pancreatitis; toxicity

Mesh:

Substances:

Year:  2018        PMID: 30216644     DOI: 10.1002/pbc.27437

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.

Authors:  Patel Zeeshan Jameel; Sham Lohiya; Amol Dongre; Sachin Damke; Bhavana B Lakhkar
Journal:  BMC Pediatr       Date:  2020-05-18       Impact factor: 2.125

2.  Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.

Authors:  Cecilie U Rank; Benjamin O Wolthers; Kathrine Grell; Birgitte K Albertsen; Thomas L Frandsen; Ulrik M Overgaard; Nina Toft; Ove J Nielsen; Peder S Wehner; Arja Harila-Saari; Mats M Heyman; Johan Malmros; Jonas Abrahamsson; Ulrika Norén-Nyström; Beata Tomaszewska-Toporska; Bendik Lund; Kirsten B Jarvis; Petter Quist-Paulsen; Goda E Vaitkevičienė; Laimonas Griškevičius; Mervi Taskinen; Ulla Wartiovaara-Kautto; Kristi Lepik; Mari Punab; Ólafur G Jónsson; Kjeld Schmiegelow
Journal:  J Clin Oncol       Date:  2019-11-26       Impact factor: 44.544

3.  National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol.

Authors:  Liv Andrés-Jensen; Mette Tiedemann Skipper; Kristian Mielke Christensen; Pia Hedegaard Johnsen; Katrine Aagaard Myhr; Martin Kaj Fridh; Kathrine Grell; A M L Pedersen; Sune Leisgaard Mørck Rubak; Martin Ballegaard; Arne Hørlyck; Rikke Beck Jensen; Trine-Lise Lambine; Kim Gjerum Nielsen; Ruta Tuckuviene; Peder Skov Wehner; Birgitte Klug Albertsen; Kjeld Schmiegelow; Thomas Leth Frandsen
Journal:  BMJ Open       Date:  2021-02-09       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.